Lipocine Inc. (LPCN)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
2. 23
-0.06
-2.6201%
$
13.41M Market Cap
- P/E Ratio
- Div Yield
20,600 Volume
-1.49 Eps
$ 2.29
Previous Close Investors:
Want to track LPCN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lipocine Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Kevin Roan Stempoint Capita LLP | 160,420 | $1.28M | $367,361.8 | -$914,394.19 | -71.34% |
 Christopher C. Powers Farther Finance Advisors, LLC | 1 | $7.99 | $2.23 | -$5.76 | -72.09% |
 Joshua Stipcich Tidemark, LLC | 59 | $188 | $135.11 | -$52.89 | -28.13% |
 BRIANNE SHERGILL Exome Asset Management LLC | 60,861 | $486,279 | $139,675.99 | -$346,603.01 | -71.28% |
 Zachary Canonico DIADEMA PARTNERS LP | 50,000 | $401,499.96 | $115,005 | -$286,494.96 | -71.36% |
| WM William Mueller Mink Brook Asset Management LLC | 66,812 | $533,828 | $152,585.25 | -$381,242.75 | -71.42% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 13,442 | $107,939.4 | $30,446.13 | -$77,493.27 | -71.79% |
